Whole-genome association studies of alcoholism with loci linked to schizophrenia susceptibility by Namkung, Junghyun et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Genetics
Open Access Proceedings
Whole-genome association studies of alcoholism with loci linked to 
schizophrenia susceptibility
Junghyun Namkung1, Youngchul Kim2 and Taesung Park*1,2
Address: 1Bioinformatics Program, Seoul National University, Seoul 151-747, South Korea and 2Department of Statistics, Seoul National 
University, Seoul 151-747, South Korea
Email: Junghyun Namkung - jh.namkung@gmail.com; Youngchul Kim - burburgy@biostats.snu.ac.kr; Taesung Park* - tspark@stats.snu.ac.kr
* Corresponding author    
Abstract
Background: Alcoholism is a complex disease. There have been many reports on significant
comorbidity between alcoholism and schizophrenia. For the genetic study of complex diseases,
association analysis has been recommended because of its higher power than that of the linkage
analysis for detecting genes with modest effects on disease.
Results: To identify alcoholism susceptibility loci, we performed genome-wide single-nucleotide
polymorphisms (SNP) association tests, which yielded 489 significant SNPs at the 1% significance
level. The association tests showed that tsc0593964 (P-value 0.000013) on chromosome 7 was
most significantly associated with alcoholism. From 489 SNPs, 74 genes were identified. Among
these genes, GABRA1 is a member of the same gene family with GABRA2 that was recently reported
as alcoholism susceptibility gene.
Conclusion:  By comparing 74 genes to the published results of various linkage studies of
schizophrenia, we identified 13 alcoholism associated genes that were located in the regions
reported to be linked to schizophrenia. These 13 identified genes can be important candidate genes
to study the genetic mechanism of co-occurrence of both diseases.
Background
Alcoholism is a complex disease that tends to run in fam-
ilies. It has been reported that alcoholism is accompanied
by many other psychiatric disorders, including schizo-
phrenia [1]. The co-occurrence of these psychiatric disor-
ders and alcoholism can be explained in several ways.
First, patients may use alcohol to relieve the symptom of
mental diseases. Second, disruption of neurochemical sys-
tems may cause psychiatric disorders and alcoholism
simultaneously. Several molecules including serotonin,
neuropeptide Y, and dopamine have been studied to
explore this hypothesis. Third, the genes responsible for
these diseases may transmit together because they are
closely linked on a chromosome and co-segregate without
any functional relationship.
Linkage or association study of polymorphisms may pro-
vide useful information on the genetic mechanism of co-
occurrence of psychiatric disorders and alcoholism.
Among psychiatric disorders, schizophrenia is also known
to be affected by multiple genes [2]. Schizophrenia
patients with substance abuse problems, especially alco-
holics, are clinically important because they usually have
a poor prognosis [3,4].
In this study, we are interested in determining whether
there is any common genetic factor that may increase the
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susceptibility of alcoholism and schizophrenia simultane-
ously. Although linkage analysis has been a successful
choice for genetic analysis of Mendelian diseases, associa-
tion analysis has shown to have greater power than link-
age analysis when used to detect genes with modest effect
on disease [5]. Thus, we conduct genome-wide associa-
tion tests to find alcoholism susceptibility loci by analyz-
ing the Collaborative Study on the Genetics of Alcoholism
(COGA) data from the Genetic Analysis Workshop 14
(GAW 14). Because COGA data were collected from mul-
tiplex families, we consider only the approaches that take
advantage of the whole pedigree data.
In our analysis, we primarily use the pedigree disequilib-
rium test (PDT) [6]. The PDT is an extension of the trans-
mission disequilibrium test (TDT) [7], and it has been
widely applied to the analysis of large pedigree data
including multiple nuclear family or sibling pairs. We test
association for both alleles and genotypes using the PDT.
Additionally, we apply the generalized estimating equa-
tions (GEE) approach [8] to test the association for each
genotype with the disease while adjusting for some phe-
notypic covariates. By using both the PDT and GEE
approaches we obtain candidate markers for alcoholism
susceptibility and then compare them with the loci that
are reported to be linked to schizophrenia.
Methods
Disease affection status was defined by using both ALDX1
(DSM-III-R+Feighner) and ALDX2 (DSM-IV). A sample
with ALDX1 = 5 or ALDX2 = 5 was defined as the affected,
and ALDX1 = 1 or ALDX2 = 1 as the unaffected. Others
treated as non-informative data. With these criteria, 668
were classified as "affected" and 285 as "unaffected" from
1,614 individuals.
Linkage analysis
For the comparison of association with the linkage analy-
sis, we first performed nonparametric linkage (NPL) anal-
ysis for microsatellites. Due to computational problems,
NPL analysis for single-nucleotide polymorphisms
(SNPs) was not performed. The linkage analysis for mic-
rosatellites was performed by using NPL procedure of
SIMWALK2 software [9]. To transform GAW14 data into
input format for SIMWALK2 software, we used MEGA2
software [10].
PDT
To test for association of microsatellites and SNPs with
disease, we used the PDT. Because the PDT is a family-
based association test, it can avoid problems of false pos-
itives caused by population stratification. There are two
types of the PDT available: allele-based PDT and geno-
type-based PDT (genotype-PDT). For the allele-based
PDT, two test statistics are commonly used: sum-PDT and
average-PDT. The sum-PDT gives more weight to families
with a larger number of multiple affected individuals. In
contrast, the average-PDT gives equal weight to all fami-
lies [11]. The genotype-PDT tests for association between
genotypes and disease. This is more powerful than the
allele-based PDT when the genetic effect of an allele is
dominant or recessive rather than additive. The genotype-
PDT can test multilocus effects without the ambiguities
associated with haplotype analysis, and allow for testing
interactions among markers [12]. We used the genotype-
PDT to test for association between disease and genotypes
at a single locus as well as at multiple loci. All the tests
were conducted by using PDT 5.1 software.
GEE
The GEE approach accounts for familial correlation in the
analysis and allows for adjustment for covariates such as
sex and age in selecting significant genotypes of SNPs. For
the binary response of disease affection status, the model
is given by
Logit [pr(Dij)] = β0 + βageageij + βsexsexij + βgenogenotypeij,
where
Dij is the affection status of jth individual in ith family
(affected = 1, unaffected = 0)
We conducted this analysis using R software http://
www.r-project.org/.
Gene finding
After identifying SNPs associated with alcoholism, we
obtained gene information from the dbSNP website http:/
/www.ncbi.nlm.nih.gov/SNP/. The additional informa-
tion of genes such as chromosomal location and func-
tional annotation was obtained from the SOURCE
website http://source.stanford.edu/. Then, we compared
the genes and regions in which they are located to pub-
lished results of various linkage studies of schizophrenia.
Results
Preliminary analysis using microsatellites
Before performing the association analysis using large
number of SNPs, we conducted linkage and association
analyses for microsatellite markers. At first, a chromo-
some-wide association test was performed using two PDT
statistics: average-PDT and sum-PDT. At the 5% signifi-
cance level (α = 0.05) for either the sum-PDT or average-
PDT, this preliminary test shows that 6 microsatellites
from chromosomes 6 and 8 tend to have associations
with alcoholism. Among them, two microsatellites are
located adjacent to the schizophrenia susceptibility region
[2,13]: 1) D6S474 (6q21) with p-values 0.0182 for theBMC Genetics 2005, 6:S9
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sum-PDT and 0.0144 for the average-PDT, 2) D8S1106
(8p21 SCZD6) with p-value 0.0155 for the sum-PDT.
To test for linkage of markers to alcoholism, we per-
formed NPL analysis. Chromosome 7 showed two peaks
of moderate linkage disequilibrium with alcoholism at
D7S673 (30.1 cM) with -log p-value 2.077 (NPL-PAIR)
and D7S820 (107.5 cM) with 2.041.
Association test for SNPs
From 15,878 autosomal SNPs, we first selected SNPs that
have  p-values smaller than 0.05 for both allele based
PDTs. One hundred and ninety SNPs had p-values less
than 0.01 and 18 SNPs had p-values less than 0.001 by
either of the two PDTs. Using the genotype-PDT we iden-
tified 138 and 16 SNPs showing significant association at
α = 0.01 and 0.001, respectively. Among 138 SNPs, 94
also showed significant associations for the allele-based
PDT at α = 0.01.
SNP tsc0593964 on chromosome 7 showed the most sig-
nificant association with alcoholism (p-value = 0.000013,
genotype-PDT). It is located about 2.3 cM away from the
modest NPL peak of D7S673 found in the linkage analysis
of microsatellites (Figure 1).
As an alternative, we also applied the GEE approach,
which considers familial correlation. From this analysis,
only 65 SNPs showed p-values less than 0.01. rs1262129
appeared to be most significant (p-value = 0.000068).
Among the 65 significant SNPs, two SNPs were also signif-
icant for the genotype-PDT: tsc0253130 (p-value =
0.0007) and tsc0834636 (p-value = 0.0054). The number
of significant SNPs is much smaller than that of PDT. It is
probably due to the lack of power caused by ignoring
genetic inheritance information in the GEE approach.
In addition, we performed multipoint association analy-
sis using the multipoint genotype-PDT. The multipoint
genotype-PDT tests for association of multiple loci with-
out haplotyping. We conducted 2-point, 3-point, and 5-
point analysis for the adjacent markers. We obtained 98
SNP pairs from the 2-point analysis, and 42 SNP triple sets
from the 3-point analysis at the 1% significance level. The
5-point analysis resulted in no significant marker sets.
Some identified SNP sets did not contain any SNP that
showed significant association from the single-locus test.
This underscores the importance of interactions among
multiple markers to search for candidate disease genes.
Using the dbSNP and the SOURCE database website, we
selected intragenic SNPs among those associated with
alcoholism. A total of 74 known genes were found to con-
tain the significant SNPs after hypothetical genes or open
reading frames were excluded. Two of these genes,
GABRA1 (tsc0325674, p-value = 0.0035 by the average-
PDT) and CHRNA3 (rs1878399, p-value = 0.0083 by the
average-PDT) are neurotransmitter receptors; NTRK2
(tsc0656804, p-value = 0.0041 by the average-PDT) has
function of neurogenesis. Of note, GABRA1 is a member
of the same gene family as GABRA2, which was reported
recently to be associated with alcoholism [14].
Finally, we compared the chromosomal location of the 74
genes with the schizophrenia susceptibility regions [2,13].
The regions were previously identified by several linkage
studies of schizophrenia. The comparison revealed that 13
genes were located in schizophrenia susceptibility region
(Table 1). These genes and SNPs on them can be putative
markers responsible for both alcoholism and schizophre-
nia susceptibility.
Summary and Discussion
Through the analysis using microsatellites, we obtained
rough regions showing modest linkage or association
with alcoholism. Later, we found that the most significant
SNP, tsc0593964, was located near the modest linkage
peak on chromosome 7.
We conducted the genome-wide association analysis for
large number of SNPs by using different association meth-
ods such as the allele-based PDT, genotype-based PDT for
single locus or for multiple loci, and GEE. Each method
resulted in a different number of significant markers.
Thus, the results should be interpreted carefully. We think
it would be important to compare the results in a more
systematic way by using simulation studies in the future.
With additional biological information such as gene
names and functions, the list of selected candidate mark-
ers may be quite useful for the study of complex disease,
even though the 1% significance level is not stringent
Linkage for microsatellites and association for SNPs on chro- mosome 7 Figure 1
Linkage for microsatellites and association for SNPs on chro-
mosome 7.
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enough for the genome-wide tests. We searched for gene
information of the selected SNPs and found that some of
the genes are related to the neurochemical system.
The evidence for significant co-morbidity of substance
abuse, especially alcoholism, and schizophrenia is very
robust [4]. The genetic relationship between two diseases
has not yet been explained. We think our findings of the
13 genes, which are associated with alcoholism and also
located in schizophrenia linkage regions, can be helpful to
study genetic factors responsible for both diseases.
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